CLINICAL EFFECTIVENESS OF COMPLEX THERAPY FOR CHRONIC ECZEMA USING AFOBAZOLE
Keywords:
Treatment, anxiolytics, eczema, Afobazole.Abstract
The anxiolytic afobazole was used for chronic eczema in the progression stage with a course dose of 360–450 mg for 12–15 days. The daily dose of the drug was 30 mg per day. To evaluate the treatment, the EASI index (Eczema Area Severity Index), the dermatological quality of life index (DLQI) and the dermatological symptom scale index (DSSI) were used. Comparison of the studied dermatological indices in patients receiving treatment with afobazole or only standard therapy showed the high effectiveness of the drug. At the end of the course of therapy, their values after using the drug were significantly lower than in the control group: DIQH - by 38%, DISHS - by 24%, EASI - by 44%.
References
Andrashko Yu. V., Mironyuk I. S. Application of Kremgen ointment for microbial eczema. Dermatology 2012; (2)
Potekaev N. S. Eczema: aspects of history, modern ideas. Clinical Dermatology and Venereology 2016; (4): 102–107.
Monakhov K. N., Ochelenko S. A. The use of modern moisturizers in violation of the skin barrier. Clinical Dermatology and Venereology 2019
Myadelets O. D., Adaskevich V. P. Morphofunctional dermatology. M.: Medlit, 2016; With. 752
